BioNTech SE (NAS:BNTX)
$ 86.52 1.97 (2.33%) Market Cap: 20.87 Bil Enterprise Value: 4.10 Bil PE Ratio: 174.62 PB Ratio: 0.95 GF Score: 66/100

BioNTech SE at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 05:00PM GMT
Release Date Price: $108.7 (-2.84%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan and we're continuing the conference today with BioNTech.

I'm joined by the company's CEO, Dr. Ugur Sahin. He's going to give a presentation on the company and then we're going to move right into Q&A. If you have a question in the room, just raise your hand and someone will bring you a microphone or alternatively, if you want to submit questions on the portal, you can do that too, and I'll read them up here.

So with that, let me turn it over to Ugur.

Ugur Sahin
BioNTech SE - Co-Founder, CEO & Chair of the Management Board

Thank you, Jessica. Good morning, everyone, and welcome also on behalf of my colleague, Jens Holstein here. I wish you -- I wish everyone a happy new year, healthy, prosperous and with peace. So some statements.

So let me start with introducing slide, which is known for many of you. BioNTech was founded 15 years ago with the vision to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot